Trial intelligence / Profile preview

Investigation of Iron and Bone Marrow Stimulation in Differential Diagnosis of Polycythemia Vera and Essential Thrombocytosis

2012-003276-39Phase 2Completed

Sponsor
Zealand University Hospital
Start
Aug 2012
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ferrous sulfate, filgrastim in polycythemia vera (PV), thrombocythemia, myeloproliferative disorder (MPD), Iron metabolism disease, sponsored by Zealand University Hospital. Started Aug 2012; status: completed.

02

Drugs

ferrous sulfatefilgrastim
03

Conditions

polycythemia vera (PV)thrombocythemiamyeloproliferative disorder (MPD)Iron metabolism disease

Beyond the preview

Go deeper on 2012-003276-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003276-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call